Market Cap (In USD)
1.09 Billion
Revenue (In USD)
-
Net Income (In USD)
-42.21 Million
Avg. Volume
233.99 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.595-22.69
- PE
- -
- EPS
- -
- Beta Value
- 1.752
- ISIN
- US74587B1017
- CUSIP
- 74587B101
- CIK
- 1625101
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Burke T. Barrett
- Employee Count
- -
- Website
- https://www.pulsebiosciences.com
- Ipo Date
- 2016-05-18
- Details
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
More Stocks
-
NIABY
-
AGXKFAnglo Asian Mining PLC
AGXKF
-
MSLVF
-
TMTNFToromont Industries Ltd.
TMTNF
-
0EDE
-
CBRGUChain Bridge I
CBRGU
-
600563Xiamen Faratronic Co., Ltd.
600563
-
APRAF